ResourceLife Sciences
Large diagnostics laboratory adopts 6-base sequencing to improve disease characterisation
1 May 2025The Munich Leukemia Laboratory (MLL) adopted biomodal’s duet evoC 6-base sequencing technology to enhance disease characterization through high-resolution methylation profiling. The technology demonstrated improved ease of use, deep genomic coverage, and low background noise, providing promising results for patient stratification and biomarker discovery in leukemia diagnostics.
Related Products
Request Quote for All Products
duet multiomics solution evoC
biomodalYour single solution for multiomics data - Uncover a true 6-base genome for unprecedented insights into current and future biological states. Access all four canonical bases and distinguish 5‑methylcytosine (5mC) and 5‑hydroxymethylcytosine (5hmC) from a single 5ng DNA sample, in a single experiment, with high accuracy.